WHO Seeks Israel's Approval for Gaza Polio Vaccination Campaign
WHO official requests Israel's cooperation for second phase of Gaza polio vaccination, proposing "tactical pauses" during campaign hours. Negotiations ongoing with meeting planned for Sunday.
The World Health Organization (WHO) has initiated discussions with Israeli authorities regarding the continuation of a crucial polio vaccination campaign in Gaza. Ayadil Saparbekov, WHO's lead for emergencies in the occupied Palestinian territory, disclosed that the organization has formally requested Israel's cooperation to commence the second phase of the vaccination effort on October 14, 2024.
Saparbekov stated, "We have approached Israeli officials to consider implementing a system similar to the one used in the initial round, which they refer to as 'tactical pauses' during the campaign's operational hours." This approach aims to ensure the safety and effectiveness of the vaccination efforts in the region.
The WHO's request highlights the ongoing challenges in conducting health initiatives in conflict-affected areas. Gaza, a self-governing Palestinian territory with a population of approximately 2 million people in an area of 365 square kilometers, has faced numerous health challenges due to ongoing conflicts and blockades.
Negotiations between the WHO and Israeli authorities are still in progress, with a meeting scheduled for October 6, 2024, to discuss the details of the upcoming vaccination phase. The outcome of these talks will be crucial for the campaign's success, as Israel has controlled Gaza's airspace and territorial waters since 2007.
The polio vaccination campaign in Gaza is part of the Global Polio Eradication Initiative, launched in 1988 to eliminate polio worldwide. This effort has made significant progress, with two of the three wild poliovirus strains now eradicated globally. The last reported case of wild poliovirus in Gaza was in 1988, underscoring the importance of continued vaccination efforts to maintain this status.
Polio, a highly infectious viral disease that can cause paralysis and death, primarily affects children under the age of five. The WHO, in collaboration with UNICEF and other partners, has been actively involved in various health initiatives in the occupied Palestinian territories, working to overcome the challenges posed by limited resources and frequent conflicts.
The success of vaccination campaigns often depends on reaching a high percentage of the target population, which is particularly challenging in conflict zones. The WHO's Emergency Committee on Polio meets regularly to assess global eradication efforts and adapt strategies to local conditions.
The proposed "tactical pauses" during the vaccination campaign hours represent a delicate balance between military operations and humanitarian needs. This approach has been used in other conflict zones where the WHO has negotiated humanitarian access to ensure the continuation of critical health services.
As negotiations continue, the international community watches closely, recognizing the importance of successful polio vaccination campaigns in maintaining global health security and progressing towards the ultimate goal of worldwide polio eradication.
